[1]叶绪英,卢成志.主动脉瓣狭窄合并疾病对经导管主动脉瓣置入术的影响[J].国际心血管病杂志,2018,01:12-15.
点击复制
主动脉瓣狭窄合并疾病对经导管主动脉瓣置入术的影响(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2018年01期
- 页码:
- 12-15
- 栏目:
- 综述
- 出版日期:
- 2018-01-25
文章信息/Info
- Title:
- -
- Author(s):
- -
- 关键词:
- 主动脉瓣狭窄; 合并疾病; 经导管主动脉瓣置入术
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-534X.2018.01.004
- 文献标识码:
- -
- 摘要:
- 近年来,经导管主动脉瓣置入术(TAVI)在不宜行外科手术的高风险主动脉狭窄患者中广泛开展。TAVI能在主动脉瓣狭窄合并冠状动脉粥样硬化性心脏病、心力衰竭、肺动脉高压等的患者中安全开展,显示了该手术良好的安全性及有效性。该文介绍常见合并疾病对TAVI治疗的影响。
- Abstract:
- -
参考文献/References
[1] Wendler O, Schymik G, Treede H, et al. SOURCE 3 registry: design and 30-day results of the European postapproval registry of the latest generation of the SAPIEN 3 transcatheter heart valve[J]. Circulation, 2017, 135(12): 1123-1132.
[2] Stefanini GG, Stortecky S, Cao D, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation[J]. Eur Heart J, 2014, 35(37):2530-2540.
[3] Snow TM, Ludman P, Banya W, et al. Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: the United Kingdom TAVI Registry[J]. Int J Cardiol, 2015, 199:253-260.
[4] Taha S, Moretti C, D’Ascenzo F, et al. Impact of residual coronary artery disease on patients undergoing TAVI: a meta-analysis of adjusted observational studies[J]. Int J Cardiol, 2015, 181:77-80.
[5] Kleczynski P, Dziewierz A, Bagienski M, et al. Impact of coronary artery disease burden on 12-month mortality of patients after transcatheter aortic valve implantation[J]. J Interv Cardiol, 2016, 29(4):375-381.
[6] Bajaj A, Pancholy S, Sethi A, et al. Safety and feasibility of PCI in patients undergoing TAVR: a systematic review and meta-analysis[J]. Heart Lung, 2017, 46(2):92-99.
[7] Singh V, Rodriguez AP, Thakkar B, et al. Comparison of outcomes of transcatheter aortic valve replacement plus percutaneous coronary intervention versus transcatheter aortic valve replacement alone in the United States[J]. Am J Cardiol, 2016, 118(11):1698-1704.
[8] Van Rosendael PJ, van Der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter aortic valve implantation[J]. Am J Cardiol, 2015, 115(12):1726-1732.
[9] Chakravarty T, Sharma R, Abramowitz Y, et al. Outcomes in patients with transcatheter aortic valve replacement and left main stenting: THE TAVR- LM REGISTRY[J]. J Am Coll Cardiol, 2016, 67(8): 951-960.
[10] Rodes-Cabau J, Masson JB, Welsh RC, et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE(aspirin versus aspirin + clopidogrel following transcatheter aortic valve implantation)randomized dinical trial[J]. JACC Cardiovasc Interv, 2017, 10(13): 1357-1365.
[11] Baumbach H, Ahad S, Hill S, et al. Transaortic transcatheter aortic valve implantation and concomitant off pump revascularization[J]. Innovations(Phila), 2016, 11(5):363-366.
[12] Castellant P, Didier R, Bezon E, et al. Comparison of outcome of transcatheter aortic valve implantation with versus without previous coronary artery bypass grafting(from the France 2 registry)[J]. Am J Cardiol, 2015, 116(3):420-425.
[13] Stortecky S, Buellesfeld L, Wenaweser P, et al. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation[J]. Circ Cardiovasc Interv, 2013, 6(1):77-84.
[14] Shaul AA, Kornowski R, Bental T, et al. Type of atrial fibrillation and clinical outcomes in patients undergoing transcatheter aortic valve replacement[J]. Ann Noninvasive Electrocardiol, 2016, 21(5):519-525.
[15] Altisent OA, Durand E, Munoz-Garcia AJ, et al. Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv, 2016, 9(16):1706-1717.
[16] Biviano AB, Nazif T, Dizon J, et al. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valve(PARTNER)trial[J]. Circ Cardiovasc Interv, 2016, 9(1):e002766.
[17] Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER(Placement of AoRtic TraNscathetER Valves)trial and registry[J]. JACC Cardiovasc Interv, 2015, 8(1 Pt A):60-69.
[18] Tempio D, Pruiti GP, Conti S, et al. Ventricular arrhythmias in aortic valve stenosis before and after transcatheter aortic valve implantation[J]. Europace, 2015, 17(7):1136-1140.
[19] Nguyen TC, Babaliaros VC, Razavi SA, et al. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement[J]. J Thorac Cardiovasc Surg, 2013, 146(6):1399-1406.
[20] Oguri A, Yamamoto M, Mouillet G, et al. Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the France 2 registry[J]. EuroIntervention, 2015, 10(9):e1-e9.
[21] Allende R, Webb JG, Munoz-Garcia AJ, et al. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients[J]. Eur Heart J, 2014, 35(38):2685-2696.
[22] Conrotto F, Salizzoni S, Andreis A, et al. Transcatheter aortic valve implantation in patients with advanced chronic kidney disease[J]. Am J Cardiol, 2017, 119(9):1438-1442.
[23] D’errigo P, Moretti C, D’ascenzo F, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in patients with chronic kidney disease stages 3b to 5[J]. Ann Thorac Surg, 2016, 102(2):540-547.
[24] Fox H, Büttner S, Hemmann K, et al. Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement[J]. J Cardiol, 2013, 61(6):423-427.
[25] Schewel D, Schewel J, Martin J, et al. Impact of transcatheter aortic valve implantation(TAVI)on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular stenosis[J]. Clin Res Cardiol, 2015, 104(2):164-174.
[26] Lu?on A, Oger E, Bedossa M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the France 2 Registry[J]. Circ Cardiovasc Interv, 2014, 7(2):240-247.
[27] O’sullivan CJ, Wenaweser P, Ceylan O, et al. Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classificati[J]. Circ Cardiovasc Interv, 2015, 8(7):e002358.
[28] Chakravarty T, Van Belle E, Jilaihawi H, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation[J]. Am J Cardiol, 2015, 115(7):942-949.
[29] Barbanti M, Webb JG, Hahn RT, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve(PARTNER)Trial Cohort A[J]. Circulation, 2013, 128(25):2776-2784.
[30] Kiramijyan S, Magalhaes MA, Koifman E, et al. Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement[J]. Am Heart J, 2016, 178:19-27.
[31] Kiramijyan S, Koifman E, Asch FM, et al. Impact of functional versus organic baseline mitral regurgitation on short- and Long-Term outcomes after transcatheter aortic valve replacement[J]. Am J Cardiol, 2016, 117(5): 839-846.
[32] Douglas PS, Hahn RT, Pibarot P, et al. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial[J]. J Am Soc Echocardiogr, 2015, 28(2): 210-217.
[33] El-Mawardy M, Wübken-Kleinfeld N, Schwarz B, et al. Transcatheter aortic valve implantation in patients with severely reduced left ventricular systolic function: a single-center experience[J]. Clin Res Cardiol, 2014, 103(8): 621-630.
[34] Testa L, Latib A, De Marco F, et al. The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation[J]. EuroIntervention, 2016, 12(12):1542-1549.
[35] Ayhan H, Durmaz T, Kele �瘙 塂 T, et al. Improvement of right ventricular function with transcatheter aortic valve implantation[J]. Scand Cardiovasc J, 2014, 48(3):184-188.
备注/Memo
- 备注/Memo:
- -
常用功能
统计/Statistics
- 摘要浏览/Viewed1
- 全文下载/Downloads2811
- 评论/Comments
